These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 5802458)
1. Monoamine oxidase inhibition in the treatment of migraine. Anthony M; Lance JW Arch Neurol; 1969 Sep; 21(3):263-8. PubMed ID: 5802458 [No Abstract] [Full Text] [Related]
2. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. Merikangas KR; Merikangas JR Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662 [TBL] [Abstract][Full Text] [Related]
3. MAOIs: still here, still dangerous. Ahmed DS; Fecik S Am J Nurs; 2000 Feb; 100(2):29-30. PubMed ID: 10683640 [No Abstract] [Full Text] [Related]
4. Management of headache by the family physician. Diamond S; Baltes BJ Am Fam Physician; 1972 Apr; 5(4):68-76. PubMed ID: 4337251 [No Abstract] [Full Text] [Related]
5. Monoamine oxidase inhibitors in the control of migraine. Anthony M; Lance JW Proc Aust Assoc Neurol; 1970; 7():45-7. PubMed ID: 4937098 [No Abstract] [Full Text] [Related]
6. Implications of the platelet monoamine oxidase deficit during migraine attacks. Sandler M Res Clin Stud Headache; 1978; 6():65-72. PubMed ID: 725258 [No Abstract] [Full Text] [Related]
7. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Nicolodi M; Sicuteri F Adv Exp Med Biol; 1996; 398():373-9. PubMed ID: 8906292 [TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. Celada P; Pérez J; Alvarez E; Artigas F J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522 [TBL] [Abstract][Full Text] [Related]
9. [Monoamine oxidase inhibitors: various clinical remarks on phenelzine]. Guyotat J; Favre-Tissot M; Marie-Cardine M J Med Lyon; 1966 Jun; 47(101):1009-15. PubMed ID: 4914860 [No Abstract] [Full Text] [Related]
10. Relationship between tranylcypromine sulfate dose and monoamine oxidase inhibition. Grasso RA; Perry PJ; Sherman AD DICP; 1991 Jan; 25(1):99-100. PubMed ID: 2008794 [No Abstract] [Full Text] [Related]
11. Rational treatment of migraine. Weber RB South Med J; 1972 Jun; 65(6):737-40. PubMed ID: 5032378 [No Abstract] [Full Text] [Related]
12. The use of sumatriptan in patients on monoamine oxidase inhibitors. Diamond S Neurology; 1995 Jun; 45(6):1039-40. PubMed ID: 7783861 [No Abstract] [Full Text] [Related]
13. Treatment of migraine. Snaith RP Br Med J; 1978 Dec; 2(6152):1645-6. PubMed ID: 728770 [No Abstract] [Full Text] [Related]
14. Monoamine oxidase inhibitors. A review of antidepressant effectiveness. Quitkin F; Rifkin A; Klein DF Arch Gen Psychiatry; 1979 Jul; 36(7):749-60. PubMed ID: 454092 [TBL] [Abstract][Full Text] [Related]
15. Successful use of phenelzine in treatment-resistant panic disorder. Buch S; Wagner M J Clin Psychiatry; 2007 Feb; 68(2):335-6. PubMed ID: 17335337 [No Abstract] [Full Text] [Related]
16. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review]. García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306 [TBL] [Abstract][Full Text] [Related]
17. [Importance of chemical mediators for the pathogenesis and treatment of hemicrania]. Berde B; Fanchamps A Minerva Med; 1976 Jun; 67(31):1991-8. PubMed ID: 1084500 [TBL] [Abstract][Full Text] [Related]